Recent studies suggest that cortical plasticity in humans is significantly modified in the presence of a single nucleotide polymorphism (val 66 met) in the gene for brain derived neurotrophic factor (BDNF). BDNF is the most abundant neurotrophin in the brain, and influences a wide range of brain events related to plasticity and repair [5] . Healthy subjects who have a copy of the val 66 met polymorphism in one or both alleles show several differences in brain structure and function, including abnormal motor cortex plasticity [3, 14] . In the U.S., this polymorphism is present in one allele in 27% of people (Val/Met), and in both alleles in 4.5% (Met/Met) [20] .
Together, these observations suggest the possibility of a role for the val 66 met polymorphism in the genesis of dystonia. As a first step, the current study sought to determine whether the prevalence of the BDNF val 66 met polymorphism in subjects with cervical dystonia, the most common adult form of dystonia, differed as compared to (a) healthy controls or (b) a cohort of subjects with a different movement disorder, Parkinson's disease. As an additional control, the prevalence of the ApoE4 genotype was also evaluated across these subject groups.
Methods
Entry criteria were for dystonia subjects were a diagnosis of dystonia based on clinical assessment with no secondary cause; and for Parkinson's disease subjects, a diagnosis of Parkinson's disease based on clinical assessment with no secondary cause. Diagnosis was by a board certified neurologist who was fellowship trained and experienced in movement disorders. Healthy controls were recruited from patient's spouses and from the community via flyers, and had no history of any type of neurological diagnosis or symptoms. All subjects were required to have age > 18 years and be English speaking.
This study was approved by the UC Irvine Institutional Review Board. All subjects signed informed consent in accordance with this approval. They then underwent exam that included scoring on the Geriatric Depression Scale (15 Q version), as well as the Toronto Western Spasmodic Torticollis Rating Scale (TWSTRS) [4] for subjects with cervical dystonia. A cheek swab was then used to obtain DNA that was processed for the BDNF val 66 met polymorphism, as described previously [14] . Subjects were classified as Val/Val if no copies of the polymorphism were present, Val/Met if one copy was present, and Met/Met if two copies were present. In all subjects, genotype for ApoE was also assessed [10] . In subjects with dystonia, genotype for DYT1 was additionally assessed [17] .
Statistical analysis was performed using JMP 7.0.1 (SAS, Cary, NC). Non-parametric methods were used to compare continuous data (Wilcoxon rank sum test), and Chi square testing to compare categorical data, across subject groups. Each pair of subject groups was evaluated independently. All analyses were two-tailed and used alpha < 0.05. Because of the rarity of the Met/Met genotype, the primary analysis focused on the distribution of the Val/ Met genotype across subject groups.
Results
A total of 141 subjects were enrolled, 34 with cervical dystonia, 54 age-matched healthy controls, and 53 subjects with Parkinson's disease. Note that none of the subjects with Parkinson's disease had a history of dystonia. The age of diagnosis for subjects with cervical dystonia was 48 ± 12 (mean ± SD) years. Fifteen subjects with cervical dystonia had a positive family history (including primary and secondary relatives) of neurological and psychiatric conditions, spanning a range of symptoms and diagnoses. The mean TWSTRS score total was 33 ± 14 (range 10-58, maximum score=87).
Demographics were overall similar across the three groups (Table) . Subjects with dystonia showed no significant differences in age, gender, ethnicity, or handedness as compared to healthy controls. However, subjects with dystonia had Geriatric Depression Scale scores (2.8 ± 2.6) that were higher than scores among healthy controls (1.2 ± 1.8, p < 0.002), though this difference was of little clinical significance given that a score > 5 points is suggestive, and > 10 diagnostic, of depression. Subjects with dystonia showed no significant differences in ethnicity, handedness, or Geriatric Depression Scale as compared to subjects with Parkinson's disease. However, mean age was slightly lower in subjects with dystonia (59 ± 13 vs. 65 ± 10, p < 0.04) and gender distributions were not matched (dystonia, 24F/ 10M; Parkinson's disease 19F/34 M; p < 0.002).
Both BDNF and ApoE were in Hardy-Weinberg equilibrium. None of the subjects with dystonia was positive for the DYT1 gene mutation.
When comparing subjects with dystonia to those with Parkinson's disease, the distribution of BDNF genotypes varied (p < 0.007), but the distribution of ApoE did not (p > 0.5). The primary analysis was that the proportion of subjects with the Val/Met BDNF genotype was significantly different (dystonia, 50%; Parkinson's disease, 19%; p<0.003, see Figure) . The proportion of subjects with ApoE4 did not differ (p > 0.75). Excluding the one subject with Parkinson's disease whose BDNF genotype was Met/Met had minimal effect on these results, as there was still a difference in the proportion of subjects with the Val/Met genotype (p < 0.003) but not the ApoE (p > 0.75).
When comparing subjects with dystonia to healthy controls, the distribution of BDNF genotypes varied (p < 0.04), but the distribution of ApoE did not (p > 0.6). The primary analysis was that the proportion of subjects with the Val/Met genotype was significantly different (dystonia, 50%; healthy controls, 28%; p<0.04, see Figure) . The proportion of subjects with ApoE4 did not differ (p > 0.55). Excluding the three healthy controls whose BDNF genotype was Met/Met had minimal effect on these results, as there was still a difference in the proportion of subjects with the Val/Met genotype (p < 0.056) but not the ApoE4 genotype (p > 0.65).
Note that when comparing subjects with Parkinson's disease to healthy controls, neither the distribution of BDNF genotypes (p > 0.25) nor ApoE (p > 0.65) varied significantly. The proportion of subjects with the Val/Met genotype (p > 0.25) or ApoE4 genotype (p > 0.75) also did not differ.
A sub-analysis found that the number of copies of ApoE2, ApoE3, or ApoE4 did not differ in any of these comparisons.
Among subjects with dystonia, BDNF genotype was not significantly related to age of onset, duration of symptoms, gender, race, handedness, positive family history, Geriatric Depression Scale score, TWSTRS total score, or value for any of the TWSTRS subscores. The distributions of BDNF and ApoE genotypes were not related (p>0.5).
Discussion
A number of abnormalities of cortical function have been described in dystonia, particularly those related to cortical representational maps and their plasticity [1, 6, 15, 21, 23, 24] . A common polymorphism for BDNF, val 66 met, has been associated with abnormal cortical plasticity [3, 14] . The current study explored whether this polymorphism might be related to the pathogenesis of dystonia by examining its prevalence. In subjects with cervical dystonia, the Val/Met genotype was approximately twice as prevalent when compared to either healthy controls or to subjects with a different movement disorder, Parkinson's disease. This was not true for the ApoE4 genotype, which was similarly distributed across subject groups.
These findings suggest the possibility that the val 66 met polymorphism might play a role in the genesis of dystonia in some subjects. The mechanism of such an effect remains unclear. The main effect of this polymorphism on BDNF function is to reduce activity-dependent secretion [7] , which is associated with reduced cortical plasticity [3, 14] and a dampening of cortical processes related to long term potentiation [3] . This is in contrast with findings in dystonia, where cortical plasticity is exaggerated [1, 6, 19, 21] . How might this BDNF genotype therefore contribute to the dystonia phenotype? One possible explanation is that the polymorphism might be a source of altered gain within sensorimotor loops, with reduced responsiveness in one node resulting in increased plasticity within a second node [19] . For example, key effects of the val 66 met polymorphism might be manifested subcortically; indeed, it has been suggested that the abnormality in dystonia might be primarily in the basal ganglia, with cortical findings in this setting thus reflecting a reaction to striatal events such as sensory gating [8, 12] . Alternatively, the impaired activity-dependent BDNF secretion associated with the polymorphism might blur the temporal resolution of either sensory processing [22] or cortical inhibition [2, 21] , each of which is suspected to contribute to the pathogenesis of dystonia.
One weakness of the study is that anxiety was not measured. Anxiety is a common psychiatric comorbidity in cervical dystonia [25] , and has also been associated with the presence of the val 66 met polymorphism [9] , and is thus a covariate of potential interest to be measured in future studies. Although the prevalence of this polymorphism among subjects with Parkinson's disease has not been reported to be abnormal, some (though not all) studies suggest that the polymorphism influences onset age [11, 13] , suggesting the utility of enrolling a different movement disorder as controls in future studies, possibly including other forms of dystonia.
A recent report from Martino et al [16] found that the distribution of BDNF genotypes among subjects with various forms of dystonia did not differ as compared to healthy controls. This remained true even when only the subgroup of subjects with cervical dystonia was analyzed. The reason for the discrepancy in results between this report and the current one is not immediately apparent. One possible explanation lies in the differing ethnicities of study enrollees, as BDNF genotypes are substantially different in Italy as compared to the US. [20] Dystonia has been suggested to be a condition whereby homeostatic mechanisms that regulate cortical plasticity become overwhelmed [8, 18] . Hallett recently suggested that a genetic cause is likely in dystonia given that the abnormality appears to be an endophenotype. The current study found that the prevalence of the BDNF val 66 met polymorphism, known to modulate cortical plasticity, is significantly increased in subjects with cervical dystonia, and so supports this hypothesis. Given that half of the current cohort of subjects with dystonia did not have the BDNF polymorphism, future studies might explore other genes that influence regulation of brain plasticity, with attention to ethnicity, and might also examine the interaction of this genotype with behavior and experience. 
